This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Urch, C E Articles by Minton, O Search for Related Content PubMed PubMed Citation Articles by Urch, C E Articles by Minton, O Social Bookmarking                   What's this?

A retrospective review of the use of alfentanil in a hospital palliative care setting

S Carr

O Minton

Department Palliative Medicine, Royal Marsden Hospital, Sutton, Surrey

Alfentanil is becoming an alternative to diamorphine when parental opioids are required, especially in the presence of renal insufficiency. Its pharmacokinetic properties suggest that tolerance may be rapidly induced, whilst concomitant administration of drugs that interfere with the cytochrome P450 system may alter its metabolism. This retrospective audit looked at the use of subcutaneous alfentanil in a palliative care setting over a 21-month period. Forty-eight out of the 81 notes identified were available for analysis. Alfentanil was used for a median of 9 days (range 1–81) with median increase in dose of 80% (range 0–1125%). No significant correlation was found between duration of infusion and dose escalation. In addition no significant correlation was found between dose escalation and concomitant drugs that either inhibited or induced the P450 system. This is the first study to investigate the use of relatively long-term use of parenteral alfentanil. The results suggest that neither tolerance nor concomitant drug administration is of clinical significance in the dose escalation.

Key Words: alfentanil • palliative care • P450 system • tolerance

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F McMunnigall and J Welsh Opioid withdrawal syndrome on switching from hydromorphone to alfentanil Palliative Medicine, March 1, 2008; 22(2): 191 - 192. [Abstract] [PDF]